NCT00204828

Brief Summary

This is an epidemiologic study, examining environmental exposures and affect on immune development.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
11 days until next milestone

Study Start

First participant enrolled

October 1, 2005

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2007

Completed
10.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

December 3, 2020

Status Verified

December 1, 2020

Enrollment Period

1.7 years

First QC Date

September 12, 2005

Last Update Submit

December 1, 2020

Conditions

Childhood Asthma

Outcome Measures

Primary Outcomes (2)

  • Childhood asthma

    3 years

  • Allergic sensitization

    3 years

Study Arms (2)

1.

Children with asthma

2.

Children without asthma

Eligibility Criteria

Age6 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

6-7 yo children of either gender

You may qualify if:

  • moderate to severe asthma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin

Madison, Wisconsin, 53792, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood, PBMC culture supes and nasal lavage

Study Officials

  • James Gern, MD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 20, 2005

Study Start

October 1, 2005

Primary Completion

June 1, 2007

Study Completion

December 1, 2017

Last Updated

December 3, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations

US(1)